These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1877113)

  • 1. Evaluation of a new bladder tumor marker.
    Grossman HB; Liebert M; Sakakibara N; Wedemeyer GA; Stein JA; Washington RW
    Urol Clin North Am; 1991 Aug; 18(3):509-13. PubMed ID: 1877113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer.
    Bonner RB; Liebert M; Hurst RE; Grossman HB; Bane BL; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):971-8. PubMed ID: 8959319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
    Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
    Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
    Fradet Y; Tardif M; Bourget L; Robert J
    Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of malignant melanoma with monoclonal antibodies.
    Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
    Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors].
    Gregersen B; Mommsen S; Svanholm H
    Ugeskr Laeger; 1999 Apr; 161(14):2071-3. PubMed ID: 10354792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New diagnostic tests for urothelial tumors of the bladder].
    Irani J
    Prog Urol; 1998 Sep; 8(4):481-6. PubMed ID: 9834508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
    Young DA; Prout GR; Lin CW
    Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human tumor associated Thomsen-Friedenreich antigen.
    Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM
    Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new tumor associated antigen from mammary carcinoma cells by monoclonal antibodies.
    Czuppon AB
    Biochem Int; 1987 Aug; 15(2):359-72. PubMed ID: 3435529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urothelial tumor markers: update].
    de Castro F; Rosell D; Agüera LG; Isa W; Sánchez de la Muela P; Robles JE; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 1990; 34(3):167-71. PubMed ID: 2101497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
    Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
    Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
    Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
    J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of bladder cancer-associated antigens and their application to diagnosis].
    Masuko T; Hashimoto Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2191-7. PubMed ID: 3606146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
    Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
    Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.